DIDM trainee closes a ₹50 Lakh deal with Shark Tank India’s most visionary shark 'Peyush Bansal'

We just informed you about one of the biggest pieces of news we had ever heard within our organization a few days ago.

It was reported that 'Mr. Puneet', our trainee who is enrolled in DIDM's digital marketing course in Gurgaon, would be pitching his revolutionary eye care product on Shark Tank India to all the sharks.

Our goal with this blog post is to inform you of what he pitched to the sharks and his results.

What happened when Mr. Puneet and his colleagues Jatin Kaushik and Amit Sahni appeared on the 34th episode of Shark Tank India, how many of the sharks were interested in investing in Mr. Puneet’s business idea, and which one of the sharks did eventually invest in his business idea?

In this blog post, we will tell you all about that and more. Unlike most of the posts we share here, this one will be a bit different. It is advised that you stay with the blog in its entirety and read it from start to finish.

DIDM trainee closes a ₹50 Lakh deal with Shark Tank India’s most visionary shark 'Peyush Bansal

If you want to get informed about CureSee, here are the brief details for you:

CureSee is the World's 1st Artificial Intelligence (AI) based vision therapy software treating Amblyopia or lazy eye. The problem it’s solving is Amblyopia which is an eye condition in which the eye cannot see clearly even with best possible spectacle or contact lens correction. The software provides personalized and adaptive therapy to patients, making it one of the most effective solutions for treating amblyopia. The company is committed to improving vision therapy and providing better results to patients worldwide.

For what purpose has this software been designed?

The software has been designed to offer patients a convenient and affordable option for treating their lazy eye.

With CureSee's software, patients can access therapy from anywhere, at any time, and on any device.

The software is easy to use and provides a comprehensive therapy experience, making it an ideal option for patients seeking significant improvement in their vision.

CureSee's vision therapy software has been widely recognized for its effectiveness and innovation.

It has been featured in several leading news publications and has received multiple accolades for its contribution to the field of vision therapy including the prestigious ZS Prize, TIDE EiR Fellowship, Scale Up Grant by Ministry of Electronics and Information Technology, Government of India.

CureSee is incubated at PIEDS, BITS Pilani and also a part of accelerator program of IIM Kozhikode.

The software has been praised for its ability to provide patients with a more comprehensive therapy experience and better results than traditional vision therapy methods.

How many people have been helped by CureSee?

CureSee's vision therapy software has already helped thousands of patients worldwide, and the company is committed to expanding its reach and helping more patients in need.

The software has been developed in collaboration with leading eye specialists and researchers, and the company continues to invest in research and development to improve its technology and provide better results to patients.

CureSee's success on Shark Tank India has brought the company to the forefront of the digital health industry.

The sharks' excitement and interest in CureSee's vision therapy software have generated immense interest in the company, and it is now poised for significant growth in the coming years.

"We are thrilled to have been featured on Shark Tank India and to have received such an overwhelming response from the sharks," said Dr. Rohan Kapoor, co-founder of CureSee.

CureSee's vision therapy software is a game-changer in the field of amblyopia treatment, and its innovative use of AI technology is paving the way for the future of vision therapy.

With its commitment to excellence and innovation, CureSee is set to change the way we approach vision therapy and bring improved vision to patients worldwide.

For more information on CureSee's vision therapy software, visit www.curesee.com.

Highlights of what happened at the 34th episode of Shark Tank India season 2 when the core team of CureSee arrived in front of the sharks.

Upon arriving at Shark Tank India, Mr. Puneet, Mr. Jatin, and Mr. Amit, CEO, CTO, and COO of CureSee, lit up with excitement.

As they made their appearance on the show, it was evident how much confidence they all have.

Since Shark Tank is a funding-based show, a person judging them as a third party could easily tell that they are highly confident about the product that they have developed and can't wait to show the sharks their revolutionary product.

Right after their arrival, they presented their unique business idea to the sharks, namely Amit Jain, Peyush Bansal, Namita Thapar, Aman Gupta, Vineeta Singh, and Anupam Mittal.

Their business was explained in detail to the sharks by all three of them.

CureSee was featured on Shark Tank India, Season 2, on the date of 16th Feb 2023 where its innovative AI-based vision therapy software for treating amblyopia, also known as lazy eye, was presented to the panel of sharks.

The software received an overwhelming response from the sharks, with each one of them vying to bag the deal.

The CureSee software uses advanced AI technology to provide personalized and effective vision therapy to patients with amblyopia, a condition that affects millions of people worldwide.

The Sharks on the show were impressed with the software's ability to provide a customized and affordable solution to people with amblyopia.

They were so impressed that they fought over the deal, with each Shark wanting a stake in CureSee.

The founders of CureSee had the difficult task of choosing the best Shark to work with, and in the end, they made a deal with one of the most well-known Sharks on the show.

The sharks were left amazed by the groundbreaking technology of CureSee's vision therapy software.

The software uses advanced AI algorithms to provide personalized and adaptive therapy to patients suffering from amblyopia.

The software adapts to the patient's progress and provides exercises tailored to their specific needs, making it one of the most effective solutions for treating amblyopia.

CureSee's vision therapy software is the world's first AI-based solution for amblyopia treatment.

Although all the sharks were willing to invest their money in CureSee but the most enthusiastic among them were Namita Thapar and Peyush Bansal. And a tough competition and deal war began in between them to get the opportunity to invest in CureSee. The most intense part was that both sharks were unwilling to come together.

After a continuous deal war, team CureSee chose Mr Peyush Bansal, the founder and CEO of Lenskart as their investor. Peyush invested Rs 50 Lakhs in CureSee for a total of 10% equity.

About Peyush Bansal

Peyush Bansal is the founder of Lenskart, India's leading online eyewear retailer.

He started the company in 2010 with the goal of making eyewear more accessible and affordable for everyone.

Since then, Lenskart has grown tremendously and now employs more than 2000 people.

Peyush has been recognized for his achievements, winning several awards including the “Young Achiever of the Year” by Entrepreneur Magazine India in 2013 and the “Entrepreneur of the Year” by the Economic Times in 2016.

He is a strong advocate of using technology to improve customer experience and has made Lenskart one of the most innovative companies in India.

He believes in constantly pushing the boundaries and challenging himself and his team to create lasting impact in the eyewear industry.

About Shark Tank India Season 2

Shark Tank India Season 2 is the second season of India's version of the popular global business reality show Shark Tank.

On the show, aspiring entrepreneurs pitch their business ideas to a panel of investors, known as 'sharks', in hopes of securing funding for their businesses.

The sharks then decide whether or not to invest in the entrepreneurs and their ideas.

Call Us
Live Chat